While many people who take GLP-1 medications for weight loss experience tremendous benefits from the drugs, the drugs may have other uses
The confirmatory secondary endpoints included the change in the 6-min walking distance, a hierarchical composite of death and heart failure events
However, they are covering them for specific conditions as supported by high-quality studies
Metformin therapy reduces obesity indices in children and adolescents: a systematic review and meta-analysis of randomized clinical trials
The biology of incretin hormones
Finally, although higher circulating levels of lipase and amylase were reported in patients on GLP-1 RA therapy in many trials, the increases were rarely higher than three or five-fold the upper limit of normal (ULN), respectively [9,10,11,12,13,14,15,16,17], returned to normal levels after medication withdrawn, and were poor predictors of AP [54]